89 related articles for article (PubMed ID: 2957118)
1. Coagulation responses to heparin in the ischemic limb: assessment of thrombin and platelet activation during vascular surgery.
Sobel M; Gervin CA; Qureshi DG; Greenfield LJ
Circulation; 1987 Sep; 76(3 Pt 2):III8-13. PubMed ID: 2957118
[TBL] [Abstract][Full Text] [Related]
2. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
3. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
Kyrle PA; Westwick J; Scully MF; Kakkar VV; Lewis GP
Thromb Haemost; 1987 Feb; 57(1):62-6. PubMed ID: 2954260
[TBL] [Abstract][Full Text] [Related]
5. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
Yudelman I
Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
7. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
9. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
11. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin and aspirin on platelet and clotting activation during leukapheresis.
Fabris F; Casonato A; Randi ML; Belloni M; Quaino V; Ongaro G; Girolami A
Eur J Clin Invest; 1985 Aug; 15(4):188-91. PubMed ID: 2931280
[TBL] [Abstract][Full Text] [Related]
13. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
[TBL] [Abstract][Full Text] [Related]
14. Peroperative anticoagulation with antithrombin or heparin in infrainguinal bypass surgery.
Nydahl S; Swedenborg J; Egberg N
Eur J Vasc Surg; 1992 Nov; 6(6):610-5. PubMed ID: 1451816
[TBL] [Abstract][Full Text] [Related]
15. Iloprost reduces procoagulant activity in the extracorporeal circuit.
Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
[TBL] [Abstract][Full Text] [Related]
16. Rational approach to use of heparin during cardiac catheterization in children.
Grady RM; Eisenberg PR; Bridges ND
J Am Coll Cardiol; 1995 Mar; 25(3):725-9. PubMed ID: 7860920
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of heparin responses in arterial and venous thromboembolism using molecular markers for thrombosis.
Sobel M; Sternbergh WC; Marques D; Grimsdale AS
Circulation; 1993 Nov; 88(5 Pt 2):II426-31. PubMed ID: 8222189
[TBL] [Abstract][Full Text] [Related]
18. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
19. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
20. Objective assessment of heparin requirements for hemodialysis in humans.
Ireland H; Lane DA; Curtis JR
J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
